HRT FINANCIAL LP

Position in PCRX — Pacira BioSciences, Inc.

CIK 1475597 NEW YORK, NY

Position in PCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,672,567

+$1,257,089 QoQ

Shares Held

65,927

+258.6% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 254 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $132,018,496 across 28 Drug Manufacturers - Specialty & Generic names. PCRX ranks #13 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	98,864	$53,567,481
2	ZTS	Zoetis Inc.	241,369	$17,344,776
3	BCRX	Biocryst Pharmaceuticals Inc	1,081,523	$10,815,230
4	TEVA	Teva Pharmaceutical Industries Ltd	295,918	$10,025,701
5	AMPH	Amphastar Pharmaceuticals, Inc.	387,530	$7,820,355
6	HLN	Haleon plc	682,281	$6,365,681
7	ANIP	Ani Pharmaceuticals Inc	63,008	$5,215,802
8	TAK	Takeda Pharmaceutical Co Ltd	278,706	$4,467,657

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,672,567	65,927	+258.6%	Shares	Defined	2026-08-14
2026-03-31	$415,478	18,384	-84.2%	Shares	Defined	2026-05-14
2025-12-31	$3,012,302	116,395	+7.3%	Shares	Defined	2026-02-12
2025-09-30	$2,794,988	108,459	-38.6%	Shares	Defined	2025-11-14
2025-03-31	$4,390,696	176,688	-1.8%	Shares	Defined	2025-05-15
2024-12-31	$3,389,334	179,901	+2607.3%	Shares	Defined	2025-02-14
2023-03-31	$271,182	6,645	-95.8%	Shares	Defined	2023-05-12
2022-12-31	$6,166,866	159,722	+624.8%	Shares	Defined	2023-02-10
2022-09-30	$1,172,148	22,037	+15.0%	Shares	Defined	2022-11-14
2021-09-30	$1,072,792	19,157	-64.7%	Shares	Defined	2021-11-15
2021-06-30	$3,295,166	54,304	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.